These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25106113)

  • 21. Fecal microbiota transplantation in treating Clostridium difficile infection.
    Brown WR
    J Dig Dis; 2014 Aug; 15(8):405-8. PubMed ID: 24825534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.
    Vindigni SM; Broussard EK; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2013 Sep; 7(7):615-28. PubMed ID: 24070153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers.
    Lo Vecchio A; Cohen MB
    Curr Opin Gastroenterol; 2014 Jan; 30(1):47-53. PubMed ID: 24275671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal microbiota transplantation-early steps on a long journey ahead.
    Khoruts A
    Gut Microbes; 2017 May; 8(3):199-204. PubMed ID: 28394706
    [No Abstract]   [Full Text] [Related]  

  • 25. Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs.
    Koenigsknecht MJ; Young VB
    Curr Opin Gastroenterol; 2013 Nov; 29(6):628-32. PubMed ID: 24100717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies.
    Kelly CR; Kunde SS; Khoruts A
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):283-8. PubMed ID: 24107393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal microbiota transplantation for management of Clostridium difficile infection.
    Vaishnavi C
    Indian J Gastroenterol; 2014 Jul; 33(4):301-7. PubMed ID: 24748025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study.
    Staley C; Hamilton MJ; Vaughn BP; Graiziger CT; Newman KM; Kabage AJ; Sadowsky MJ; Khoruts A
    Am J Gastroenterol; 2017 Jun; 112(6):940-947. PubMed ID: 28195180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection.
    Brandt LJ
    Am J Gastroenterol; 2013 Feb; 108(2):177-85. PubMed ID: 23318479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.
    Núñez F P; Quera R; Bay C; Thomson P
    Gastroenterol Hepatol; 2022 Mar; 45(3):223-230. PubMed ID: 34118321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal microbiota transplantation: indications, methods, evidence, and future directions.
    Borody TJ; Paramsothy S; Agrawal G
    Curr Gastroenterol Rep; 2013 Aug; 15(8):337. PubMed ID: 23852569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.
    Khoruts A; Staley C; Sadowsky MJ
    Nat Rev Gastroenterol Hepatol; 2021 Jan; 18(1):67-80. PubMed ID: 32843743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation.
    Fujimoto K; Kimura Y; Allegretti JR; Yamamoto M; Zhang YZ; Katayama K; Tremmel G; Kawaguchi Y; Shimohigoshi M; Hayashi T; Uematsu M; Yamaguchi K; Furukawa Y; Akiyama Y; Yamaguchi R; Crowe SE; Ernst PB; Miyano S; Kiyono H; Imoto S; Uematsu S
    Gastroenterology; 2021 May; 160(6):2089-2102.e12. PubMed ID: 33577875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of recurrent and severe Clostridium difficile infection.
    Keller JJ; Kuijper EJ
    Annu Rev Med; 2015; 66():373-86. PubMed ID: 25587656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal microbiota transplantation: a new old kid on the block for the management of gut microbiota-related disease.
    Cammarota G; Ianiro G; Bibbò S; Gasbarrini A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S80-4. PubMed ID: 25291136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging metabolic view of Clostridium difficile pathogenesis.
    Hryckowian AJ; Pruss KM; Sonnenburg JL
    Curr Opin Microbiol; 2017 Feb; 35():42-47. PubMed ID: 27997854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stool transplants: ready for prime time?
    Weissman JS; Coyle W
    Curr Gastroenterol Rep; 2012 Aug; 14(4):313-6. PubMed ID: 22585070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent Clostridium difficile infection and the microbiome.
    Almeida R; Gerbaba T; Petrof EO
    J Gastroenterol; 2016 Jan; 51(1):1-10. PubMed ID: 26153514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.